Locally Advanced Nsclc | List of Frontiers open access articles

Case Report

Published on 24 Jul 2023

Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report

in Thoracic Oncology

Jiantao Wang
Wenqing Yao
Weiya Wang
Mingyu Fan
Kaili Huang
Zhenkun Liu
Daxing Zhu

Frontiers in Oncology

doi 10.3389/fonc.2023.1164543

3,158 views
3 citations

Clinical Trial

Published on 05 Jul 2023

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

in Thoracic Oncology

Christian Wilhelm Langberg
Henrik Horndalsveen
Åslaug Helland
Vilde Drageset Haakensen

Frontiers in Oncology

doi 10.3389/fonc.2023.1217424

3,395 views
3 citations

Original Research

Published on 31 May 2012

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer

in Radiation Oncology

Howard Safran
Thomas DiPetrillo
Humera Khurshid
Thomas Ng
Kalyan Mantripragada
Ariel Birnbaum
David Berz
Kathy Radie-Keane
Kimberly Perez
Maria Constantinou

Frontiers in Oncology

doi 10.3389/fonc.2012.00056

6,345 views
13 citations

Original Research

Published on 06 Aug 2025

Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach

in Thoracic Oncology

Filippo Tommaso Gallina
Riccardo Tajè
Daniele Forcella
Gabriele Alessandrini
Francesco Vizza
Rachele Bovini
Paolo Visca
Isabella Sperduti
Federico Cappuzzo

Frontiers in Oncology

doi 10.3389/fonc.2025.1579943

1,640 views

Original Research

Published on 01 Dec 2025

Machine learning–based prognostic modeling for locally advanced non-small cell lung cancer treated with immuno-radiotherapy

in Pharmacology of Anti-Cancer Drugs

Simin Lu
Xin Zheng
Yi Wang
Yafei Li
Xuan Yu
Yan Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1723874

938 views

Original Research

Published on 09 Apr 2025

Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study

in Cancer Immunity and Immunotherapy

Jingyun Yang
Tianxiang Cui
Yang Zhang
Guangpeng Chen
Xinxin Wang
Jianguo Sun
Anmei Zhang
Guanghui Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557154

2,383 views

Original Research

Published on 03 Mar 2026

Cross-dataset adaptation of voxel-level deep radiomics for predicting survival in inoperable locally advanced NSCLC treated with immunotherapy

in Cancer Immunity and Immunotherapy

Jin Wang
Zhaoyu Jiang
Wenhao Ji
Han Cheng
Zhen Zhang
Andre Dekker
Leonard Wee
Meng Yan
Xiaojing Lai

Frontiers in Immunology

doi 10.3389/fimmu.2026.1787518

199 views

Original Research

Published on 28 Jan 2026

The predictive value of modified-Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy

in Cancer Immunity and Immunotherapy

Yang Wang
Chunyan Tang
Junyuan Bing
Rebeka Dejenie
Yanfei Zhang
Fangchao Li
Xiaolong Fang
Xiaotong Chen
Min Yang
Yunxia Zang

Frontiers in Immunology

doi 10.3389/fimmu.2026.1748521

487 views

Original Research

Published on 22 May 2025

The predictive value of Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy

in Cancer Immunity and Immunotherapy

Yanfei Zhang
Chunyan Tang
Min Yang
Shixuan Li
Fangchao Li
Yang Wang
Li Qi
Jingjing Li

Frontiers in Immunology

doi 10.3389/fimmu.2025.1578896

2,669 views
1 citation

Original Research

Published on 18 Nov 2013

Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer

in Radiation Oncology

Vittorio Donato
Stefano Arcangeli
Alessia Monaco
Cristina Caruso
Michele Cianciulli
Genoveva Boboc
Cinzia Chiostrini
Roberta Rauco
Maria Cristina Pressello

Frontiers in Oncology

doi 10.3389/fonc.2013.00286

5,396 views
11 citations

Original Research

Published on 24 Jul 2025

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients

in Thoracic Oncology

Dong Lin
Liang Wu
Pei Wang
Xiaolong Li
Xiaolan Wang
Yiran Cai
Kangli Xiong
Xi Chen
Fu Yang
Wei Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1563315

2,242 views

Original Research

Published on 17 Feb 2021

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

in Radiation Oncology

Xin Sui
Leilei Jiang
Huajing Teng
Lan Mi
Bo Li
Anhui Shi
Rong Yu
Dongming Li
Xin Dong
Dan Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.625911

4,742 views
14 citations

Original Research

Published on 18 Aug 2022

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer

in Thoracic Oncology

Byung-Hee Kang
Xue Li
Jaeman Son
Changhoon Song
Hyun-Cheol Kang
Hak Jae Kim
Hong-Gyun Wu
Joo Ho Lee

Frontiers in Oncology

doi 10.3389/fonc.2022.891221

3,601 views
9 citations

Review

Published on 14 Dec 2022

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

in Thoracic Oncology

Annika Dhawan
Phillip M. Pifer
Vlad C. Sandulache
Heath D. Skinner

Frontiers in Oncology

doi 10.3389/fonc.2022.1016217

5,530 views
6 citations

Brief Research Report

Published on 19 Sep 2023

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

in Radiation Oncology

Emily S. Lebow
Narek Shaverdian
Jordan E. Eichholz
Leah B. Kratochvil
Megan McCune
Yonina R. Murciano-Goroff
Justin Jee
Juliana Eng
Jamie E. Chaft
Mark G. Kris

Frontiers in Oncology

doi 10.3389/fonc.2023.1253629

10,306 views
21 citations

Original Research

Published on 01 Dec 2021

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth

in Cancer Immunity and Immunotherapy

Eva Reijmen
Sven De Mey
Helena Van Damme
Kirsten De Ridder
Thierry Gevaert
Emmy De Blay
Luc Bouwens
Christine Collen
Lore Decoster
Marijke De Couck

Frontiers in Immunology

doi 10.3389/fimmu.2021.772555

8,947 views
12 citations

Articles

Complete pathological response and negative postoperative ctDNA were not predictive of discontinuation of adjuvant crizotinib therapy in a patient with locally advanced MET ex14 skipping mutation-positive non-small cell lung cancer: a case report

Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC

A Phase I Study of Dasatinib with Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer

Short term outcomes of robotic surgery after neoadjuvant treatment for locally advanced NSCLC: a comparison with the open approach

Machine learning–based prognostic modeling for locally advanced non-small cell lung cancer treated with immuno-radiotherapy

Breaking barriers: harnessing hypofractionated radiotherapy to transform outcomes in low tumor mutation burden stage III non-small cell lung cancer - a retrospective study

Cross-dataset adaptation of voxel-level deep radiomics for predicting survival in inoperable locally advanced NSCLC treated with immunotherapy

The predictive value of modified-Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy

The predictive value of Naples prognostic score for patients with locally advanced non-small cell lung cancer undergoing surgery after neoadjuvant chemotherapy

Moderately Escalated Hypofractionated (Chemo) Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer

Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients

Prediction of Clinical Outcome in Locally Advanced Non-Small Cell Lung Cancer Patients Treated With Chemoradiotherapy by Plasma Markers

Prediction and clinical impact of delayed lymphopenia after chemoradiotherapy in locally advanced non-small cell lung cancer

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth